Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
About Tirzepatide About Tirzepatide Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, under active clinical evaluation
How GLP-1 Medications Slow Digestion GLP-1 medications are known for slowing gastric emptying, meaning food remains in the stomach longer before moving through the digestive tract
Liraglutide Suppresses Obesity and Induces Brown Fat-like Phenotype Via Soluble Guanylyl Cyclase Mediated Pathway In Vivo and In Vitro
Retatrutide is available in multiple vial strengths so research teams can select the format that best matches their controlled laboratory workflow
The market is driven by the increasing prevalence of obesity and type 2 diabetes throughout the world, the effectiveness of GLP-1 agonists in terms of significant weight loss and glucose management, and active consumer promotion campaigns and reimbursement coverage
US$ 26.32
US$ 20.62
US$ 23.04
US$ 22.29
US$ 24.52
US$ 28.41
US$ 28.30
US$ 26.84
US$ 23.62
